Autoimmune diseases, such as celiac disease, multiple sclerosis, and type 1 diabetes, are
leading causes of morbidity and mortality in the United States. In these disease states …

Unwanted antibody responses significantly impact human health, and current options for
treating deleterious antibody responses largely rely on broad immunosuppressants that can …

In the slipstream of targeting the adaptive immune system, innate immunotherapy strategies
are being developed. In this context, technologies based on natural carrier vehicles that …

This study aims to provide guidelines to design and perform a robust and reliable physical-
chemical characterization of liposome-based nanomaterials, and to support method …

Impairment of immune tolerance might cause autologous tissue damage or overactive
immune response against non-pathogenic molecules. Although autoimmune disease and …

Cell-based therapies for autoimmune diseases have gained significant traction, with several
approaches centered around the regulatory T (Treg) cell─ a well-known …

Autoimmune diseases occur when cells of the adaptive immune system incorrectly
recognize and attack “self” tissues. Importantly, the proliferation and differentiation of these …

Background Transcutaneous vaccines have received wide attention due to their easy-to-
use, needle-free, noninvasive delivery. However, the novel barrier function of stratum …

Autoimmune diseases affect 10% of the world's population, and 1 in 200 people worldwide
suffer from either multiple sclerosis (MS) or type 1 diabetes (T1D). While the targeted organ …